MicroRNA-24/MODY gene regulatory pathway mediates pancreatic β-cell dysfunction

Diabetes

Volumn 62, Issue 9, 2013, Pages 3194-3206

  Zhu, Yunxia ^a   You, Weiyan ^a   Wang, Hongdong ^a   Li, Yating ^a   Qiao, Nan ^a   Shi, Yuguang ^b   Zhang, Chenyu ^c   Bleich, David ^d   Han, Xiao ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c NANJING UNIVERSITY   (China)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 24; MICRORNA; MIRN24 MICRORNA, HUMAN; MIRN24 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE TARGETING; INSULIN RELEASE; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; CELL LINE; CELL SURVIVAL; CYTOLOGY; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; PANCREAS ISLET; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; FLOW CYTOMETRY; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; MICRORNAS; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84887363120     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0151     Document Type: Article

References (50)

1. Wajchenberg BL. beta-Cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007;28:187-218
2. Lindgren CM, McCarthy MI. Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Nat Clin Pract Endocrinol Metab 2008;4:156-163
3. Leroith D, Accili D. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008;4:164-172
4. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocaña A. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 2005;54: 2090-2102
5. Hao E, Tyrberg B, Itkin-Ansari P, et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 2006; 12:310-316
6. Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death? Science 2005;307:380-384
7. Cheung L, Zervou S, Mattsson G, et al. c-Myc directly induces both impaired insulin secretion and loss of b-cell mass, independently of hyper-glycemia in vivo. Islets 2010;2:37-45
8. Kim HY, Kim K. Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic b-cell mass in the hypoglycemic effects of Korean red ginseng in Goto-Kakizaki rats. J Ethnopharmacol 2012;142:53-58
9. Yeom SY, Kim GH, Kim CH, et al. Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2. Mol Cell Biol 2006;26:4553-4563
10. Matsumura K, Chang BH, Fujimiya M, et al. Aquaporin 7 is a beta-cell protein and regulator of intraislet glycerol content and glycerol kinase activity, beta-cell mass, and insulin production and secretion. Mol Cell Biol 2007;27:6026-6037
11. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-980
12. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002;34:207-216
13. Hunter CS, Maestro MA, Raum JC, et al. Hnf1a (MODY3) regulates b-cell-enriched MafA transcription factor expression. Mol Endocrinol 2011;25: 339-347
14. Wang L, Coffinier C, Thomas MK, et al. Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. Endocrinology 2004;145:3941-3949
15. Kushner JA, Ye J, Schubert M, et al. Pdx1 restores beta cell function in Irs2 knockout mice. J Clin Invest 2002;109:1193-1201
16. Rubio-Cabezas O, Minton JA, Kantor I, Williams D, Ellard S, Hattersley AT. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes 2010;59:2326-2331
17. Flatt PR, Green BD. Nutrient regulation of pancreatic beta-cell function in diabetes: problems and potential solutions. Biochem Soc Trans 2006;34: 774-778
18. Newsholme P, Gaudel C, McClenaghan NH. Nutrient regulation of insulin secretion and beta-cell functional integrity. Adv Exp Med Biol 2010;654:91-114
19. Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005;54(Suppl. 2):S108-S113
20. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005;54(Suppl. 2):S97-S107
21. Ohtsubo K, Chen MZ, Olefsky JM, Marth JD. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat Med 2011;17:1067-1075
22. Gu C, Stein GH, Pan N, et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab 2010;11:298-310
23. Hagman DK, Hays LB, Parazzoli SD, Poitout V. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 2005;280: 32413-32418
24. Falus A, Molnár V. Closer to the completed unity: messenger and micro-RNA profiling. An introduction. Semin Cancer Biol 2008;18:77-78
25. Wang M, Xie H, Mi S, Chen J. Recent patents on the identification and clinical application of microRNAs and target genes. Recent Pat DNA Gene Seq 2007;1:116-124
26. Zhang B, Wang Q, Pan X. MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 2007;210:279-289
27. Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007;23:243-249
28. Cuperus JT, Fahlgren N, Carrington JC. Evolution and functional diversification of MIRNA genes. Plant Cell 2011;23:431-442
29. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009;11:228-234
30. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005;132:4653-4662
31. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Onco-gene 2008;27:5959-5974
32. Zhao E, Keller MP, Rabaglia ME, et al. Obesity and genetics regulate mi-croRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome 2009;20:476-485
33. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 2011;31:3182-3194
34. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 2009;15:287-293
35. Poy MN, Hausser J, Trajkovski M, et al. miR-375 maintains normal pancreatic a-and b-cell mass. Proc Natl Acad Sci USA 2009;106:5813-5818
36. Bravo-Egana V, Rosero S, Molano RD, et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem Bio-phys Res Commun 2008;366:922-926
37. Lovis P, Roggli E, Laybutt DR, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic b-cell dysfunction. Diabetes 2008;57:2728-2736
38. Melkman-Zehavi T, Oren R, Kredo-Russo S, et al. miRNAs control insulin content in pancreatic b-cells via downregulation of transcriptional repressors. EMBO J 2011;30:835-845
39. Zaidi SK, Dowdy CR, van Wijnen AJ, et al. Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res 2009;69:8249-8255
40. Lal A, Pan Y, Navarro F, et al. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009;16:492-498
41. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007;21: 578-589
42. Lal A, Navarro F, Maher CA, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell 2009;35:610-625
43. Hatziapostolou M, Polytarchou C, Aggelidou E, et al. An HNF4a-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011;147:1233-1247
44. Zhu Y, Shu T, Lin Y, et al. Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic b-cells. Biochem Biophys Res Commun 2011;404:159-165
45. Rossmeisl M, Rim JS, Koza RA, Kozak LP. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes 2003;52:1958-1966
46. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, Yokoi T. MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 2010;285:4415-4422
47. Huang S, He X, Ding J, et al. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 2008;123:972-978
48. Newsholme P, Rebelato E, Abdulkader F, Krause M, Carpinelli A, Curi R. Reactive oxygen and nitrogen species generation, antioxidant defenses, and b-cell function: a critical role for amino acids. J Endocrinol 2012;214: 11-20
49. Eitel K, Staiger H, Rieger J, et al. Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 2003;52:991-997
50. Tang C, Han P, Oprescu AI, et al. Evidence for a role of superoxide generation in glucose-induced beta-cell dysfunction in vivo. Diabetes 2007;56: 2722-2731